BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 22513527)

  • 1. Human papillomavirus-associated cancers - United States, 2004-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Apr; 61():258-61. PubMed ID: 22513527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Papillomavirus-Associated Cancers - United States, 2008-2012.
    Viens LJ; Henley SJ; Watson M; Markowitz LE; Thomas CC; Thompson TD; Razzaghi H; Saraiya M
    MMWR Morb Mortal Wkly Rep; 2016 Jul; 65(26):661-6. PubMed ID: 27387669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.
    Watson M; Saraiya M; Ahmed F; Cardinez CJ; Reichman ME; Weir HK; Richards TB
    Cancer; 2008 Nov; 113(10 Suppl):2841-54. PubMed ID: 18980203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.
    Ryerson AB; Peters ES; Coughlin SS; Chen VW; Gillison ML; Reichman ME; Wu X; Chaturvedi AK; Kawaoka K
    Cancer; 2008 Nov; 113(10 Suppl):2901-9. PubMed ID: 18980273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK
    J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
    Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
    Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region.
    Parkin DM; Louie KS; Clifford G
    Vaccine; 2008 Aug; 26 Suppl 12():M1-16. PubMed ID: 18945410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Papillomavirus-Attributable Cancers - United States, 2012-2016.
    Senkomago V; Henley SJ; Thomas CC; Mix JM; Markowitz LE; Saraiya M
    MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):724-728. PubMed ID: 31437140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US.
    Saraiya M; Ahmed F; White M; Lawson H; Unger ER; Eheman C
    Cancer; 2008 Nov; 113(10 Suppl):2837-40. PubMed ID: 18980202
    [No Abstract]   [Full Text] [Related]  

  • 10. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
    Jemal A; Simard EP; Dorell C; Noone AM; Markowitz LE; Kohler B; Eheman C; Saraiya M; Bandi P; Saslow D; Cronin KA; Watson M; Schiffman M; Henley SJ; Schymura MJ; Anderson RN; Yankey D; Edwards BK
    J Natl Cancer Inst; 2013 Feb; 105(3):175-201. PubMed ID: 23297039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concerned about HPV-related cancer rise, researchers advocate boosting HPV vaccination rates.
    Azvolinsky A
    J Natl Cancer Inst; 2013 Sep; 105(18):1335-6. PubMed ID: 23990671
    [No Abstract]   [Full Text] [Related]  

  • 12. Genitoanal human papillomavirus infection and associated neoplasias.
    Gross G
    Curr Probl Dermatol; 2014; 45():98-122. PubMed ID: 24643181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of male HPV vaccination in the United States.
    Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
    Vaccine; 2011 Oct; 29(46):8443-50. PubMed ID: 21816193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HPV infection in males: an update.
    Giraldi G; De Luca d'Alessandro E
    Ann Ig; 2012; 24(6):497-506. PubMed ID: 23234187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
    Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
    J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
    Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
    JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
    Broomall EM; Reynolds SM; Jacobson RM
    Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancers attributable to human papillomavirus infection.
    Grulich AE; Jin F; Conway EL; Stein AN; Hocking J
    Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003.
    Ekwueme DU; Chesson HW; Zhang KB; Balamurugan A
    Cancer; 2008 Nov; 113(10 Suppl):2936-45. PubMed ID: 18980277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The disease burden of human papillomavirus in men is substantial and can potentially be prevented].
    Kiellberg Larsen H; Kofoed K; Sand C
    Ugeskr Laeger; 2013 Feb; 175(6):349-53. PubMed ID: 23402241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.